prior authorization for semaglutide GL5197E (Wegovy), Manulife Group Benefits Drug Form (Wegovy/Semaglutide) – GL5197E - MLI (08/2025-WEGOV) TrimRX | How to Get

Evidence: Well-established additive CNS depression

Research: The SCALE trial assessed weight loss outcomes in people with obesity receiving a once-daily injection of liraglutide over 14 months (56 weeks)

The STEP 4 Randomized Clinical Trial followed 803 adults who were overweight or obese, 79% of whom were women

It can also cause low blood sugar levels, which can lead to dizziness, lightheadedness, and fainting

Structurally, biochar presents an irregular, porous matrix with mixed composition, containing amorphous carbon domains, residual cellulose, lignin fragments, and various mineral impurities 82

Your physician can assess whether this combination is appropriate for your specific situation and can monitor for any unexpected effects